跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Mabiclav - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Mabiclav
Approved
STANDARD
Mabiclav
Indchemie Health Specialities Private Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
fddb30c06eac82c2
Company
Indchemie Health Specialities Private Limited
Type
Standard
Approval Details
Approval Id
fddb30c06eac82c2
Drug Approval Philippines Name
Mabiclav
Product Name
Mabiclav
Registration Number
DRP-1077-18
Brand Name
Mabiclav
Generic Name
Co-Amoxiclav
Dosage Form
Tablet
Dosage Strength
625 mg
Manufacturer
Indchemie Health Specialities Private Limited
Importer
Suhitas Pharmaceuticals Inc
Distributor
Medconcern Drugs And General Merchandise Inc
Issuance Date
27 October 2023
Expiry Date
07 October 2028
Pharmacologic Category
Antibacterial (Penicillin)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
fddb30c06eac82c2
Type
Standard
Back to Philippines FDA Approvals